# A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)

> **NCT00796367** · PHASE3 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 676 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** VI-0521
- **DRUG:** Placebo
- **DRUG:** VI-0521

## Key facts

- **NCT ID:** NCT00796367
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 676 (ACTUAL)
- **Last updated:** 2012-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796367, "A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00796367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*